- 1. Ipratropium/Albuterol
- [A combination of albuterol and ipratropium with a bronchodilatory effect. Albuterol stimulates beta2-adrenergic receptors in the lungs, thereby activating the enzyme adenylate cyclase that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'- adenosine monophosphate (cAMP). This results in the relaxation of bronchial smooth muscle, relieve of bronchospasms, and reduction of inflammatory cell mediator release. Ipratropium is a synthetic quaternary ammonium compound and a competitive muscarinic acetylcholine (Ach) receptor antagonist. This agent inhibits vagally mediated reflexes by antagonizing the action of Ach and consequently, prevents the increase in intracellular cyclic guanosine monophosphate, which is a result of ACh interacting with the muscarinic receptor on bronchial smooth muscle. ( NCI )] (UMLS (NCI) C0717386) =Organic Chemical; Pharmacologic Substance ;
| - 3. IPROCLOZIDE
- (UMLS (NCI) C0063841) =Organic Chemical; Pharmacologic Substance ;
|
- 2. Iprivask
- (UMLS (NCI) C1259412) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 4. iproniazid
- [An irreversible inhibitor of monoamine oxidase types A and B that is used as an antidepressive agent. It has also been used as an antitubercular agent, but its use is limited by its toxicity. ( MSH )] (UMLS (CSP) C0022059) =Organic Chemical; Pharmacologic Substance
|
home
